NM_020822.3:c.3178-7_3178-3dupTGCCC
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 8P and 16B. PVS1BP6_Very_StrongBS1BS2
The NM_020822.3(KCNT1):c.3178-7_3178-3dupTGCCC variant causes a splice acceptor, intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0057 ( 3 hom., cov: 0)
Exomes 𝑓: 0.0063 ( 23 hom. )
Consequence
KCNT1
NM_020822.3 splice_acceptor, intron
NM_020822.3 splice_acceptor, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.600
Publications
1 publications found
Genes affected
KCNT1 (HGNC:18865): (potassium sodium-activated channel subfamily T member 1) Potassium channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a sodium-activated potassium channel subunit which is thought to function in ion conductance and developmental signaling pathways. Mutations in this gene cause the early-onset epileptic disorders, malignant migrating partial seizures of infancy and autosomal dominant nocturnal frontal lobe epilepsy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2012]
KCNT1 Gene-Disease associations (from GenCC):
- childhood-onset epilepsy syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- developmental and epileptic encephalopathy, 14Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- malignant migrating partial seizures of infancyInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
- autosomal dominant nocturnal frontal lobe epilepsy 5Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- autosomal dominant nocturnal frontal lobe epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
PVS1
Splicing +-2 bp (donor or acceptor) variant, LoF is a know mechanism of disease, No cryptic splice site detected. Exon removal results in frameshift change.
BP6
Variant 9-135786170-C-CGCCCT is Benign according to our data. Variant chr9-135786170-C-CGCCCT is described in ClinVar as Benign. ClinVar VariationId is 196185.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00574 (865/150638) while in subpopulation AMR AF = 0.00868 (132/15210). AF 95% confidence interval is 0.00747. There are 3 homozygotes in GnomAd4. There are 411 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check.
BS2
High AC in GnomAd4 at 865 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00575 AC: 865AN: 150524Hom.: 3 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
865
AN:
150524
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00488 AC: 962AN: 197052 AF XY: 0.00464 show subpopulations
GnomAD2 exomes
AF:
AC:
962
AN:
197052
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00634 AC: 8863AN: 1397248Hom.: 23 Cov.: 12 AF XY: 0.00629 AC XY: 4377AN XY: 696296 show subpopulations
GnomAD4 exome
AF:
AC:
8863
AN:
1397248
Hom.:
Cov.:
12
AF XY:
AC XY:
4377
AN XY:
696296
show subpopulations
African (AFR)
AF:
AC:
99
AN:
30558
American (AMR)
AF:
AC:
275
AN:
38858
Ashkenazi Jewish (ASJ)
AF:
AC:
88
AN:
25144
East Asian (EAS)
AF:
AC:
161
AN:
38610
South Asian (SAS)
AF:
AC:
257
AN:
81932
European-Finnish (FIN)
AF:
AC:
168
AN:
50462
Middle Eastern (MID)
AF:
AC:
18
AN:
5596
European-Non Finnish (NFE)
AF:
AC:
7428
AN:
1068114
Other (OTH)
AF:
AC:
369
AN:
57974
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.444
Heterozygous variant carriers
0
388
776
1164
1552
1940
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
278
556
834
1112
1390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00574 AC: 865AN: 150638Hom.: 3 Cov.: 0 AF XY: 0.00559 AC XY: 411AN XY: 73584 show subpopulations
GnomAD4 genome
AF:
AC:
865
AN:
150638
Hom.:
Cov.:
0
AF XY:
AC XY:
411
AN XY:
73584
show subpopulations
African (AFR)
AF:
AC:
136
AN:
40752
American (AMR)
AF:
AC:
132
AN:
15210
Ashkenazi Jewish (ASJ)
AF:
AC:
18
AN:
3466
East Asian (EAS)
AF:
AC:
21
AN:
5068
South Asian (SAS)
AF:
AC:
12
AN:
4744
European-Finnish (FIN)
AF:
AC:
33
AN:
10470
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
498
AN:
67646
Other (OTH)
AF:
AC:
15
AN:
2086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
40
80
119
159
199
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Mar 31, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Developmental and epileptic encephalopathy, 14;C3554306:Autosomal dominant nocturnal frontal lobe epilepsy 5 Benign:1
Jul 19, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Developmental and epileptic encephalopathy, 14 Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Jan 26, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Autosomal dominant nocturnal frontal lobe epilepsy 5 Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.